IRVINE, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. ("AEON” or the "Company”) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 (prabotulinumtoxinA) as a ...
IRVINE, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE American: AEON), a biopharmaceutical company advancing ABP-450 (prabotulinumtoxinA) as a ...
THE WOODLANDS, TX, March 04, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (AMIX) (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision ...
LONDON and NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of ...
HAMPTON, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that multiple presentations from the Company’s Phase 2 clinical trials of barzolvolimab in chronic spontaneous ...
Abracadabra 2026, the pre-primary class presentations of NPS International School, Mysuru, were held with great excitement and creativity. The programme was inaugurated by Principal Akhila Dinesh, who ...
-- Chiesi’s abstract presentations will focus on clinical insights and patient-reported outcomes inFabry disease and alpha-mannosidosis -- -- These scientific contributions in lysosomal storage ...
Currently my repo(Android & iOS combined) is using java-client version: 8.3.0 I did not update my version since I got issues with the new byte buddy library. I tried ...
This page provides answers to the most commonly asked questions regarding abstract submission, confidentiality, and presentation policies. Questions are listed together at the top of the page for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results